An official website of the United States government
Here's how you know
A .mil website belongs to an official U.S. Department of Defense organization in the United States.
A lock (lock ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

Home : News : News
NEWS | Aug. 24, 2021

New scopolamine auto-injector tested at JBSA-Camp Bullis

By Jose E. Rodriguez U.S. Army Medical Center of Excellence Public Affairs

The U.S. Army Medical Test and Evaluation Activity, known as USAMTEAC, conducted a customer test for a scopolamine auto-injector at the Deployable Medical System Equipment for Training site at Joint Base San Antonio-Camp Bullis Aug. 17.

USAMTEAC, formally called the Army Medical Department Board, is part of the U.S. Army Medical Center of Excellence at JBSA-Fort Sam Houston and provides independent operational testing and evaluation of medical and medical-related materiel and information technology products in support of the Army`s Department of Defense acquisition processes.

The test was conducted for the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, or JPEO-CBRND, to test the effectiveness of the auto-injector in a simulated battlefield environment with the test players wearing Level 4 Mission Oriented Protective Posture, or MOPP, protective gear.

Test players came from across MEDCoE, along with Brooke Army Medical Center and U. S. Army Regional Health Command-Central.

Results and data of the auto-injector will be sent to JPEO-CBRND for their evaluation and possible future fielding throughout the Army.